c-Myc tag Peptide: Mechanistic Evidence & Immunoassay Application

Executive Summary: The c-Myc tag Peptide (SKU A6003) is a synthetic peptide corresponding to the C-terminal residues 410-419 of human c-Myc, widely used for displacing c-Myc-tagged fusion proteins in immunoassays (APExBIO). It acts as a specific inhibitor of anti-c-Myc antibody binding, improving assay precision and reducing background in detection workflows [internal]. The c-Myc protein is a proto-oncogenic transcription factor that regulates cell proliferation, apoptosis, and differentiation, with its dysregulation implicated in cancer (Wu et al. 2021). The peptide demonstrates exceptional solubility in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with sonication) but is insoluble in ethanol. Proper storage at -20°C and avoidance of long-term solutions are essential for stability and reproducibility.

Biological Rationale

The c-Myc tag Peptide mimics the C-terminal epitope of the human c-Myc protein, a 439-amino acid transcription factor encoded by the MYC proto-oncogene. c-Myc regulates transcription of genes involved in cell cycle progression, growth, apoptosis, and stem cell self-renewal (Wu et al. 2021). Overexpression or gene amplification of MYC is frequently observed in diverse human cancers, driving uncontrolled proliferation and metabolic reprogramming. The 10-amino acid tag (EQKLISEEDL) is routinely fused to recombinant proteins to facilitate detection and purification in immunoassays [internal]. Synthetic c-Myc tag peptides displace c-Myc-tagged proteins from antibody complexes, enabling elution or competitive binding studies. This approach is central to immunoprecipitation, western blot, and competitive ELISA workflows. The c-Myc tag system enables precise investigation of transcription factor stability, post-translational modifications, and proto-oncogene function.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide acts as a competitive inhibitor for anti-c-Myc antibodies, such as clone 9E10. The peptide's sequence, derived from residues 410-419 (EQKLISEEDL), is recognized with high specificity by these monoclonal antibodies. Upon introduction to an assay, the free peptide binds antibody paratopes, displacing c-Myc-tagged fusion proteins or blocking antibody-antigen interaction. This mechanism is exploited for eluting fusion proteins from affinity matrices, mapping antibody specificity, and controlling for non-specific background in immunodetection [internal]. The approach does not modify the protein of interest but transiently disrupts antibody recognition. The c-Myc tag Peptide is soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (sonicated), but is insoluble in ethanol (APExBIO). Stability is maximized by storing the desiccated peptide at -20°C and minimizing freeze-thaw cycles.

Evidence & Benchmarks

• The c-Myc tag (EQKLISEEDL) is a validated epitope recognized by multiple commercial monoclonal antibodies, including clone 9E10 (Wu et al. 2021).
• Synthetic c-Myc tag peptides enable efficient displacement of c-Myc-tagged fusion proteins from immobilized antibodies in immunoprecipitation assays (internal guide).
• The peptide demonstrates solubility ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with sonication, supporting robust handling in standard laboratory buffers (APExBIO).
• Specificity for antibody binding inhibition is confirmed in competitive ELISA and western blot, with minimal cross-reactivity to unrelated tags or proteins (internal benchmark).
• c-Myc protein function, as a transcription factor, is mechanistically linked to cell cycle gene activation (e.g., cyclins), ribosomal biogenesis, and suppression of cell cycle inhibitors (e.g., p21), underscoring its oncogenic potential (Wu et al. 2021).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is an established tool in molecular biology and cancer research. Its primary applications include:

• Competitive displacement of c-Myc-tagged proteins in immunoprecipitation and affinity purification assays.
• Blocking or validating anti-c-Myc antibody specificity in western blot or immunofluorescence.
• Elution of tagged proteins for downstream proteomic or structural studies.
• Controls for background signal in c-Myc-related immunoassays, enhancing reproducibility.

This article updates prior summaries by integrating recent mechanistic insights on transcription factor regulation and benchmarking solubility/stability parameters against newly published standards [internal]. While previous guides ([internal reference]) discussed autophagy's impact on transcription factor stability, this review focuses on the synthetic peptide's practical utility and evidence-based performance.

Common Pitfalls or Misconceptions

• Diagnostic Use: The c-Myc tag Peptide is not validated for human diagnostic or therapeutic applications; it is strictly for research use only (APExBIO).
• Solubility in Ethanol: The peptide is insoluble in ethanol and should not be dissolved in alcoholic buffers.
• Long-Term Solution Storage: Prolonged storage of peptide solutions leads to degradation; always store lyophilized at -20°C and freshly prepare solutions before use.
• Antibody Cross-Reactivity: The peptide's blocking ability is specific to anti-c-Myc antibodies and does not inhibit unrelated antibody interactions.
• Epitope Mutations: Proteins with mutated or truncated c-Myc tags may not be displaced efficiently by the peptide.

Workflow Integration & Parameters

For optimal performance, dissolve the c-Myc tag Peptide in DMSO (≥60.17 mg/mL) or water (≥15.7 mg/mL, ultrasonic treatment recommended). Typical working concentrations in immunoprecipitation range from 0.1 to 1 mM, but titration is advised for assay-specific optimization. Store desiccated peptide at -20°C; avoid repeated freeze-thaw cycles. Prepare fresh solutions prior to each use. The peptide can be used in displacement studies, competitive ELISA, or as a blocking reagent in western blot analysis. For troubleshooting or protocol adaptation, refer to the A6003 kit documentation or comparative guides [internal]. This performance-focused review clarifies and updates earlier workflow recommendations by integrating new solubility and specificity benchmarks.

Conclusion & Outlook

The c-Myc tag Peptide (SKU A6003) from APExBIO remains a gold-standard reagent for displacement of c-Myc-tagged fusion proteins and antibody binding inhibition. Its mechanism, solubility, and specificity are supported by peer-reviewed evidence and rigorous product documentation. Future research will expand on the interplay between c-Myc regulation, autophagy, and transcription factor stability, further increasing assay reliability in cancer and immunology studies (Wu et al. 2021). For detailed protocols, troubleshooting, and mechanistic updates, see the c-Myc tag Peptide product page and recent comparative analyses (internal).